SNORA11E: A Potential Drug Target and Biomarker (G101340250)

Target Name: SNORA11E

NCBI ID: G101340250

SNORA11E

Other Name(s): small nucleolar RNA, H/ACA box 11E | Small nucleolar RNA, H/ACA box 11E

SNORA11E: A Potential Drug Target and Biomarker

SNORA11E is a gene that has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene is located on chromosome 11 and encodes a protein known as SNORA11E.

SNORA11E is a transmembrane protein that is expressed in various tissues and cells throughout the body. It is involved in several cellular processes, including cell signaling, cell adhesion, and intracellular signaling. SNORA11E has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of SNORA11E is its ability to interact with other proteins at the cell surface. This interaction allows SNORA11E to regulate a wide range of cellular processes, including cell signaling, cell adhesion, and intracellular signaling. SNORA11E has been shown to play a role in several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.

In addition to its role in cellular signaling, SNORA11E has also been shown to be involved in several diseases. For example, SNORA11E has been shown to be involved in the development and progression of cancer. Several studies have shown that SNORA11E is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, SNORA11E has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

SNORA11E has also been shown to be involved in the regulation of autoimmune disorders. In several studies, SNORA11E has been shown to play a role in the development and regulation of autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis.

In conclusion, SNORA11E is a gene that has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its ability to interact with other proteins at the cell surface and its involvement in several cellular processes make it an attractive target for drug development. Further research is needed to fully understand the role of SNORA11E in these diseases and to develop effective treatments.

Protein Name: Small Nucleolar RNA, H/ACA Box 11E

The "SNORA11E Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA11E comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets